237 related articles for article (PubMed ID: 15843146)
1. Characterization of the glyoxalases of the malarial parasite Plasmodium falciparum and comparison with their human counterparts.
Akoachere M; Iozef R; Rahlfs S; Deponte M; Mannervik B; Creighton DJ; Schirmer H; Becker K
Biol Chem; 2005 Jan; 386(1):41-52. PubMed ID: 15843146
[TBL] [Abstract][Full Text] [Related]
2. Distinct subcellular localization in the cytosol and apicoplast, unexpected dimerization and inhibition of Plasmodium falciparum glyoxalases.
Urscher M; Przyborski JM; Imoto M; Deponte M
Mol Microbiol; 2010 Apr; 76(1):92-103. PubMed ID: 20149108
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum glyoxalase II: Theorell-Chance product inhibition patterns, rate-limiting substrate binding via Arg(257)/Lys(260), and unmasking of acid-base catalysis.
Urscher M; Deponte M
Biol Chem; 2009 Nov; 390(11):1171-83. PubMed ID: 19663684
[TBL] [Abstract][Full Text] [Related]
4. Catalysis and structural properties of Leishmania infantum glyoxalase II: trypanothione specificity and phylogeny.
Silva MS; Barata L; Ferreira AE; Romão S; Tomás AM; Freire AP; Cordeiro C
Biochemistry; 2008 Jan; 47(1):195-204. PubMed ID: 18052346
[TBL] [Abstract][Full Text] [Related]
5. Allosteric coupling of two different functional active sites in monomeric Plasmodium falciparum glyoxalase I.
Deponte M; Sturm N; Mittler S; Harner M; Mack H; Becker K
J Biol Chem; 2007 Sep; 282(39):28419-28430. PubMed ID: 17664277
[TBL] [Abstract][Full Text] [Related]
6. Tight-binding inhibitors efficiently inactivate both reaction centers of monomeric Plasmodium falciparum glyoxalase 1.
Urscher M; More SS; Alisch R; Vince R; Deponte M
FEBS J; 2012 Jul; 279(14):2568-78. PubMed ID: 22607473
[TBL] [Abstract][Full Text] [Related]
7. Glyoxalase I from Leishmania donovani: a potential target for anti-parasite drug.
Padmanabhan PK; Mukherjee A; Singh S; Chattopadhyaya S; Gowri VS; Myler PJ; Srinivasan N; Madhubala R
Biochem Biophys Res Commun; 2005 Dec; 337(4):1237-48. PubMed ID: 16236261
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and structural characterization of Salmonella typhimurium glyoxalase II: new insights into metal ion selectivity.
Campos-Bermudez VA; Leite NR; Krog R; Costa-Filho AJ; Soncini FC; Oliva G; Vila AJ
Biochemistry; 2007 Oct; 46(39):11069-79. PubMed ID: 17764159
[TBL] [Abstract][Full Text] [Related]
9. Structure, evolution, and inhibitor interaction of S-adenosyl-L-homocysteine hydrolase from Plasmodium falciparum.
Bujnicki JM; Prigge ST; Caridha D; Chiang PK
Proteins; 2003 Sep; 52(4):624-32. PubMed ID: 12910461
[TBL] [Abstract][Full Text] [Related]
10. A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization.
Krungkrai SR; DelFraino BJ; Smiley JA; Prapunwattana P; Mitamura T; Horii T; Krungkrai J
Biochemistry; 2005 Feb; 44(5):1643-52. PubMed ID: 15683248
[TBL] [Abstract][Full Text] [Related]
11. Glyoxalase I of the malarial parasite Plasmodium falciparum: evidence for subunit fusion.
Iozef R; Rahlfs S; Chang T; Schirmer H; Becker K
FEBS Lett; 2003 Nov; 554(3):284-8. PubMed ID: 14623080
[TBL] [Abstract][Full Text] [Related]
12. A possible regulatory role of 17beta-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells.
Rulli A; Antognelli C; Prezzi E; Baldracchini F; Piva F; Giovannini E; Talesa V
Breast Cancer Res Treat; 2006 Mar; 96(2):187-96. PubMed ID: 16319983
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the gene encoding glyoxalase II from Leishmania donovani: a potential target for anti-parasite drugs.
Padmanabhan PK; Mukherjee A; Madhubala R
Biochem J; 2006 Jan; 393(Pt 1):227-34. PubMed ID: 16159313
[TBL] [Abstract][Full Text] [Related]
14. Bivalent transition-state analogue inhibitors of human glyoxalase I.
Zheng ZB; Creighton DJ
Org Lett; 2003 Dec; 5(25):4855-8. PubMed ID: 14653691
[TBL] [Abstract][Full Text] [Related]
15. Specificity of the trypanothione-dependent Leishmania major glyoxalase I: structure and biochemical comparison with the human enzyme.
Ariza A; Vickers TJ; Greig N; Armour KA; Dixon MJ; Eggleston IM; Fairlamb AH; Bond CS
Mol Microbiol; 2006 Feb; 59(4):1239-48. PubMed ID: 16430697
[TBL] [Abstract][Full Text] [Related]
16. The crystal structure of Plasmodium falciparum glutamate dehydrogenase, a putative target for novel antimalarial drugs.
Werner C; Stubbs MT; Krauth-Siegel RL; Klebe G
J Mol Biol; 2005 Jun; 349(3):597-607. PubMed ID: 15878595
[TBL] [Abstract][Full Text] [Related]
17. The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitors.
Maric S; Donnelly SM; Robinson MW; Skinner-Adams T; Trenholme KR; Gardiner DL; Dalton JP; Stack CM; Lowther J
Biochemistry; 2009 Jun; 48(23):5435-9. PubMed ID: 19408962
[TBL] [Abstract][Full Text] [Related]
18. Ferredoxin-NADP+ reductase from Plasmodium falciparum undergoes NADP+-dependent dimerization and inactivation: functional and crystallographic analysis.
Milani M; Balconi E; Aliverti A; Mastrangelo E; Seeber F; Bolognesi M; Zanetti G
J Mol Biol; 2007 Mar; 367(2):501-13. PubMed ID: 17258767
[TBL] [Abstract][Full Text] [Related]
19. The glyoxalase pathway in protozoan parasites.
Sousa Silva M; Ferreira AE; Gomes R; Tomás AM; Ponces Freire A; Cordeiro C
Int J Med Microbiol; 2012 Oct; 302(4-5):225-9. PubMed ID: 22901378
[TBL] [Abstract][Full Text] [Related]
20. Human malaria parasite orotate phosphoribosyltransferase: functional expression, characterization of kinetic reaction mechanism and inhibition profile.
Krungkrai SR; Aoki S; Palacpac NM; Sato D; Mitamura T; Krungkrai J; Horii T
Mol Biochem Parasitol; 2004 Apr; 134(2):245-55. PubMed ID: 15003844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
